Scientific resource
Poster
Poster
07/04/2024
Intra-cranial administration of MTL-004, a promising post-resection treatment for glioblastoma
Gliomas (GBM), are exceptionally hard to treat, aggressive and genetically heterogeneous tumors. Read the poster to discover the case study!
Poster
07/04/2024
Evaluation of checkpoint inhibitor efficacy in a humanized immune system mouse model lacking murine Fc gamma receptors
Humanized immune system (HIS) mice are critical immuno-oncology tools for evaluating antibody-based therapeutic target engagement and efficacy in a human-like context
Poster
07/04/2024
New technologies and capabilities supporting the development of novel Molecular RadioTherapy agents
Read our Oncodesign-Services' poster which provides cutting-edge technologies and products to support the development of radiopharmaceuticals for theranostics.
Poster
07/04/2024
Examples of translational preclinical models to mimic cancer drug resistance
Resistance mechanisms are now well studied in vitro, based on mutated cell lines for specific resistance pathways. Discover our poster!
Poster
05/02/2024
Advancing Drug Discovery through 3D Cell Models: Unveiling Novel Hits and Mechanisms
Discover our findings highlight the importance of 3D cell models in drug discovery. Download the poster!
Poster
09/05/2023
Generative AI Empowers the Search for PIM-1 Kinase Inhibitors: unveiling Novel Promising Chemical Entities
Discover this new poster co-written by Oncodesign Services and Iktos on the Generative AI Empowers the Search for PIM-1 Kinase Inhibitors.
Poster
03/04/2023
Preclinical evaluation of a chimpanzee adenovirus vector expressing a pre-fusion Spike (BV-AdCoV-1) SARS-CoV-2 intranasal vaccine candidate in golden Syrian hamsters
Download the e-poster and learn more about Chimpanzee Adenovirus vector SARS-CoV-2 intranasal Vaccine Candidate from Oncodesign Services.
Poster
28/03/2023
New target identification and validation platform combining AI in oncology and preclinical pharmacology
The OncoSNIPE® project combines Ai in Oncology and Preclinical Pharmacology to develop a new identification and validation platform. Learn more here
Poster
28/03/2023
DRIVE-Biologics: all the steps from discovery to development of novel biological therapeutics
DRIVE-Biologics aims to optimize your biologics therapeutics and drug discovery through stages of preclinical evaluation to clinical studies. Learn more here
Poster
28/03/2023
Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical melanoma model
Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical Melanoma Model. Learn more here
Poster
28/03/2023
OncoTAM, a comprehensive preclinical platform to explore macrophages
OncoTAM targets Tumor Associated Macrophages to develop new Anticancer Therapies in a form of a comprehensive preclinical platform. Learn more here
Poster
28/03/2023
Antitumor activity comparison of two somatostatin receptor ligands radiolabeled with Lutetium-177 (SSO110 and DOTA-TATE)
Somatostatin Receptor ligands Antitumor Activity comparison radiolabeled with Lutetium 177 alone or combined with chemotherapy in mice. Learn more here